首页> 外文期刊>Basic & clinical pharmacology & toxicology. >A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, NON-INFERIORITY CLINICAL TRIAL TO COMPARE THE CLINICAL AND RADIOLOGICAL EFFICACY OF 625 VS. 1250 MG OF ORAL METHYLPREDNISOLONE IN PATIENTS WITH RELAPSE OF MULTIPLE SCLEROSIS: THE ORAL-CORTEM TRIAL
【24h】

A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, NON-INFERIORITY CLINICAL TRIAL TO COMPARE THE CLINICAL AND RADIOLOGICAL EFFICACY OF 625 VS. 1250 MG OF ORAL METHYLPREDNISOLONE IN PATIENTS WITH RELAPSE OF MULTIPLE SCLEROSIS: THE ORAL-CORTEM TRIAL

机译:一项多中心、随机、双盲、非劣效性临床试验,以比较 625 与 625 的临床和放射学疗效。1250 MG 口服甲泼尼龙治疗多发性硬化症复发患者:口服 CORTEM 试验

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号